Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [Internet]. 11 aprile 2026 [citato 12 aprile 2026];40(2). Disponibile su: https://ojshostng.com/index.php/njphysiologicalsciences/article/view/4001